Call us free: +44 800 193 0027

Now shipping to over 180 countries worldwide

Food law experts concerned about CBD novel foods process as FSA reveals first products list

The FSA has published its promised list of CBD products that can remain on sale​ until it decides whether to authorise the products.

The list contains 22 products from just three companies: Chanelle McCoy Health (Pureis), CANNABIS Pharma s.r.o, and Health Innovations (UK) ltd.

Companies in England and Wales had to submit their novel foods dossiers to the FSA by March 31st if they wanted their CBD products to be able to legally remain on the market.  

The FSA promised that it would provide the industry with a list of products this month, associated with applications which either: have been validated in the initial stage of the process before going on to the safety assessment; or are ‘on hold’, with applicants having set out robust plans to complete the risk assessment but yet to supply all the information needed to continue on in the process.

Local authorities will need to use the lists in order to enforce the law and ensure only legal products are being sold.

Emily Miles, Chief Executive of the Food Standards Agency, says companies who didn’t submit a dossier to the FSA by March 31st should remove their products from the market, adding: “Products on the list that have been linked to a validated or on hold application will now undergo a full safety assessment so that a final decision can be made.

“When complete, the list can be used by suppliers and retailers to confirm the status of particular products and to help local authorities inform their enforcement decisions.

“The FSA is not endorsing the sale of any of these products, regardless of whether they are on the list or not and inclusion on the list is no guarantee of eventual authorisation; that will be determined on the strength of evidence of safety submitted by the companies.”

Source link
CBD Sale
Leave a Reply

Your email address will not be published.